FDA Under Scrutiny on Pharmaceutical Safety Faced with a series of major lapses in drug safety, the Food and Drug Administration announces new measures to rectify the situation. Meanwhile, a new study is being published in the Lancet showing that the heart attack risks of Vioxx were clear four years ago. NPR's Richard Knox reports.

FDA Under Scrutiny on Pharmaceutical Safety

FDA Under Scrutiny on Pharmaceutical Safety

  • Download
  • <iframe src="https://www.npr.org/player/embed/4155649/4155650" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">

Faced with a series of major lapses in drug safety, the Food and Drug Administration announces new measures to rectify the situation. Meanwhile, a new study is being published in the Lancet showing that the heart attack risks of Vioxx were clear four years ago. NPR's Richard Knox reports.